Cascade Catalytic Nanoplatform Based on "Butterfly Effect" for Enhanced Immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• The tumor microenvironment (TME) often exhibits immunosuppressive properties, hindering conventional cancer treatments.
• Developing nanoplatforms that leverage TME components offers a promising therapeutic strategy.

Purpose of the Study:

• To develop a cascade catalytic nanoplatform (IONP-GOD@ART) for enhanced cancer immunotherapy by utilizing TME substances.
• To investigate the therapeutic efficacy of IONP-GOD@ART in triggering immunogenic cell death and reprogramming the immunosuppressive TME.

Main Methods:

• Fabrication of IONP-GOD@ART nanoplatform by modifying mesoporous iron oxide nanoparticles (IONP) with glucose oxidase (GOD) and loading Artemisinin (ART).
• Utilizing GOD to convert glucose into gluconic acid and H2O2 for tumor starvation and Fenton reaction.
• Employing IONP to release iron ions for Fenton reaction and ART to generate reactive oxygen species (ROS).

Main Results:

• The nanoplatform effectively generated substantial ROS through a cascade catalytic process.
• IONP-GOD@ART induced immunogenic cell death and promoted M1-TAMs polarization.
• The nanoplatform demonstrated potent cancer immunotherapy, leading to tumor regression and prevention of metastasis.

Conclusions:

• The IONP-GOD@ART nanoplatform successfully manipulates the TME to generate ROS, enhancing cancer immunotherapy.
• This approach offers a novel strategy for overcoming TME-mediated immunosuppression and improving therapeutic outcomes.